DYSPLASTIC NAEVUS SYNDROME side effect
What is DYSPLASTIC NAEVUS SYNDROME ?DYSPLASTIC NAEVUS SYNDROME : Elidel Side Effects Report #5589907-X
Physician from UNITED STATES reported ELIDEL problem on Jan 04, 2008. Male patient, 14 years of age, was diagnosed with dermatitis atopic and was treated with ELIDEL. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, . ELIDEL dosage: unknown. Patient recovered.
DYSPLASTIC NAEVUS SYNDROME : Elspar Side Effects Report #5573595-2
ELSPAR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2007. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ELSPAR. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, malignant melanoma, . ELSPAR dosage: unknown. During the same period patient was treated with PREDNISONE, METHOTREXATE, MERCAPTOPURINE, VINCRISTINE, DAUNORUBICIN, CYCLOPHOSPHAMIDE. Patient recovered.
DYSPLASTIC NAEVUS SYNDROME : Enbrel Side Effects Report #5385231-9
Physician from GERMANY reported ENBREL problem on July 06, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, malignant melanoma in situ, superficial spreading melanoma stage i, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.
DYSPLASTIC NAEVUS SYNDROME : Mercaptopurine Side Effects Report #5390945-0
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Male patient was diagnosed with b-cell type acute leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, malignant melanoma in situ, . MERCAPTOPURINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, VINCRISTINE, ASPARAGINASE, DAUNORUBICIN, METHOTREXATE. Patient recovered.
DYSPLASTIC NAEVUS SYNDROME : Enbrel Side Effects Report #5385231-9
Physician from GERMANY reported ENBREL problem on July 06, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, malignant melanoma in situ, superficial spreading melanoma stage i, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.
DYSPLASTIC NAEVUS SYNDROME : Mercaptopurine Side Effects Report #5390945-0
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Male patient was diagnosed with b-cell type acute leukaemia and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: dysplastic naevus syndrome, malignant melanoma in situ, . MERCAPTOPURINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, VINCRISTINE, ASPARAGINASE, DAUNORUBICIN, METHOTREXATE. Patient recovered.
DYSPLASTIC NAEVUS SYNDROME : Fosamax Side Effects Report #5568569-1
Consumer or non-health professional from UNITED STATES reported FOSAMAX problem on Nov 28, 2006. Female patient, 55 years of age, weighting 145.0 lb, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: abscess oral, diverticulum, dysplastic naevus syndrome, haemorrhoids, nausea, oral mucosal blistering, osteoarthritis, osteonecrosis, paraesthesia oral, . FOSAMAX dosage: 5 MG DAILY PO; 35 MG WKY PO. During the same period patient was treated with PREMPRO. Patient recovered.